Price target
249.310.00 0.00%
The 13 analysts offering 1 year price forecasts for 0RG8 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 14 analysts giving stock ratings to 0RG8 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
0RG8 EPS for the last quarter is 0.86 EUR despite the estimation of 0.90 EUR. In the next quarter EPS is expected to reach 1.06 EUR. Track more of SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) financials and stay on top of what is up with the company.
In the next quarter SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) revenue is expected to reach 706.12 M EUR. Check out SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) revenue and earnings and make informed decisions.
According to analysts, 0RG8 price target is 249.31 EUR with a max estimate of 360.00 EUR and a min estimate of 150.00 EUR. Check if this forecast comes true in a year, meanwhile watch SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) stock price chart and keep track of the current situation with 0RG8 news and stock market news.
We've gathered opinions of 14 analysts rating 0RG8 stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.